Cargando…
2804. Azole versus echinocandin combination therapy for the treatment of invasive mucormycosis: A case series
BACKGROUND: Mucormycosis is a rare and aggressive mold infection with an all-cause mortality of 54%. Treatment for mucormycosis has historically consisted of high dose liposomal amphotericin B (LAmB) as monotherapy. Recent data has emerged studying combination therapies; however, this data is confli...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679367/ http://dx.doi.org/10.1093/ofid/ofad500.2415 |